04/19
Headlines

MACK

Gilead Sciences GILD NASDAQ:GILD

Hot Biotech Watch List: InterMune Inc (NASDAQ:ITMN), Merrimack Pharmaceuticals (NASDAQ:MACK), China Biologic Products (NASDAQ:CBPO), VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA)

Kristen Barton03 mins

InterMune, Inc. (NASDAQ:ITMN) on 27 May 2014 announced that it has resubmitted its pirfenidone New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in response to a Complete Response Letter (CRL) received in May 2010. Pirfenidone is being developed for the treatment of adult patients with idiopathic pulmonary fibrosis (IPF). InterMune Inc…

Read More
Gilead Sciences GILD NASDAQ:GILD

Biotech GAiners: BioCryst Pharmaceuticals (NASDAQ:BCRX), Dyax Corp. (NASDAQ:DYAX), Novavax, Inc. (NASDAQ:NVAX), Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

Kevin Long02 mins

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shares closed up nearly 11% on Tuesday after the company reported positive data from its OPuS-1 mid-stage study involving BCX4161 as a treatment for hereditary angioedema, or HAE. This is a rare immune disorder that can cause swelling of the face, breathing airways, and also causes abdominal cramping. According to the…

Read More

Volatile Stocks: MeetMe Inc (NASDAQ:MEET), Merrimack Pharmaceuticals Inc (NASDAQ:MACK), Pernix Therapeutics Holdings Inc (NASDAQ:PTX), Dillard’s (NYSE:DDS), Just Energy Group (NYSE:JE)

Kristen Barton03 mins

MeetMe Inc (NASDAQ:MEET), the public market leader for social discovery, has released Icebreakers, a new feature for the MeetMe iPhone app that makes it easier for users to start a chat. “Icebreakers solves the problem of the empty chat screen,” said Geoff Cook, CEO of MeetMe. “Rather than starting conversations with a generic ‘Hi’ or…

Read More

Recent Insider Buying: AOL, Inc. (NYSE:AOL), Tyco International Ltd. (NYSE:TYC), Merrimack Pharmaceuticals Inc (NASDAQ:MACK), Emerson Electric Co. (NYSE:EMR)

Jason Knox02 mins

AOL Inc (NYSE:AOL) CEO Timothy M. Armstrong purchased 55,600 shares of AOL Inc (NYSE:AOL) stock in a transaction that occurred on Thursday, May 8th. The stock was purchased at an average cost of $36.08 per share, for a total transaction of $2,006,048.00. AOL, Inc. (NYSE:AOL) stock performance was 3.71% in last session and finished the…

Read More

NASDAQ Losers: ON Semiconductor Corp (NASDAQ:ONNN), Endocyte (NASDAQ:ECYT), Actuate Corp (NASDAQ:BIRT), Merrimack Pharmaceuticals (NASDAQ:MACK)

Colin Pettis02 mins

ON Semiconductor Corp (NASDAQ:ONNN)’s adjusted earnings totaled $75.2 million, or 17 cents a share, while revenue increased year over year to $706.5 million from $661 million. Analysts polled by Thomson Reuters expected the company to earn 15 cents a share on revenue of $711.67 million. The company issued second-quarter revenue guidance in the range of…

Read More